Recombinant Chlamydophila caviae DNA mismatch repair protein MutS (mutS), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, but this can be adjusted as needed.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
mutS; CCA_00829; DNA mismatch repair protein MutS
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Chlamydophila caviae (strain GPIC)
Target Names
mutS
Uniprot No.

Target Background

Function

This protein participates in DNA mismatch repair, potentially mediating mismatch recognition. It exhibits weak ATPase activity.

Database Links
Protein Families
DNA mismatch repair MutS family

Q&A

What is the primary function of MutS in Chlamydophila caviae?

MutS in C. caviae, similar to its homologs in other bacterial species, serves as the primary recognition component of the DNA mismatch repair (MMR) system. It recognizes and binds to DNA base pair mismatches that occur during DNA replication. Upon binding to these mismatches, MutS initiates a cascade of molecular events involving other proteins such as MutL to correct these errors. This process is crucial for maintaining genomic integrity by ensuring high fidelity of DNA replication, typically enhancing accuracy by 100-200 fold. In C. caviae specifically, MutS plays an essential role in limiting spontaneous mutations that could affect the bacterium's pathogenicity and adaptation to different host environments .

How does the MutS protein structure relate to its function in DNA repair?

While specific structural data for C. caviae MutS is limited, based on homology with well-characterized MutS proteins from other bacterial species, it likely possesses a modular structure with multiple functional domains. These typically include:

  • An N-terminal mismatch-binding domain that directly interacts with DNA mismatches

  • A connector domain linking the mismatch-binding domain to the core

  • A lever domain facilitating conformational changes

  • A clamp domain encircling the DNA

  • An ATPase domain providing energy for conformational changes

  • A helix-turn-helix motif involved in DNA binding

How does the MutS-mediated DNA repair pathway operate in C. caviae?

The MutS-mediated DNA repair pathway in C. caviae likely follows the methyl-directed mismatch repair (MMR) mechanism observed in other bacteria. The process begins when MutS identifies and binds to mismatched base pairs or small insertion/deletion loops in the DNA. This MutS-mismatch complex then enables the docking of MutL, which in turn recruits and activates additional repair machinery. In many bacteria, MutH, a methylation-sensitive endonuclease, distinguishes between the parental and newly synthesized DNA strands by detecting methylation patterns. It then selectively nicks the unmethylated (newly synthesized) strand .

Following this nick, additional proteins including helicase, single-strand binding proteins, exonucleases, DNA polymerase, and DNA ligase collaborate to remove the erroneous segment and replace it with the correct sequence, thereby completing the repair process. Although the specific details of this pathway in C. caviae require further characterization, the core mechanisms are likely conserved based on the high conservation of DNA repair pathways across bacterial species .

What are the implications of MutS overexpression in Chlamydia species?

MutS overexpression can have paradoxical effects on bacterial cells. Based on studies in E. coli, overexpression of MutS leads to impairment of DNA mismatch repair rather than enhancing it. This results in increased mutation rates, particularly transition mutations (GC to AT). The research indicates that higher MutS overexpression promotes DNA double-strand breaks, inhibits cell division, and causes a significant increase in bacterial cell length .

In E. coli, MutS overexpression specifically resulted in:

  • A 3-fold higher rate of GC to AT transition mutations

  • Promotion of DNA double-strand breaks

  • Induction of SOS response

  • Inhibition of cell division through novel MutS-FtsZ interaction

  • Increased cell length

For C. caviae, as an obligate intracellular pathogen with a more streamlined genome, MutS overexpression might have even more pronounced effects on cellular function and viability, potentially affecting its developmental cycle, inclusion morphology, and host-pathogen interactions .

What role might MutS play in the zoonotic potential of C. caviae?

The zoonotic potential of C. caviae, including its ability to cross species barriers and cause infections in humans, may be influenced by MutS function in several significant ways:

  • Genomic Stability Maintenance: MutS likely ensures that critical virulence genes remain intact during zoonotic transmission, maintaining the pathogen's ability to establish infection in a new host species.

  • Adaptive Mutation Control: The ability of some C. caviae strains to infect humans despite primarily being guinea pig pathogens may rely on an optimal balance of genomic stability and adaptive mutation, regulated in part by MutS activity .

  • Host-Specific Adaptation: When C. caviae transitions between animal and human hosts, it faces different selection pressures. MutS function might be crucial for managing genetic changes necessary for adaptation while preserving core functions.

  • Interaction with Recombination Systems: Recent research has demonstrated that interspecies genetic exchange can occur in Chlamydia species. MutS may interact with recombination systems to influence the incorporation of DNA acquired through horizontal gene transfer, potentially facilitating or limiting the acquisition of host-specific virulence factors .

Notably, while the laboratory C. caviae GPIC strain has not been reported to cause human infections, recent clinical isolates of C. caviae have been identified as zoonotic agents in cases of severe community-acquired pneumonia, suggesting potentially significant genetic differences that could involve DNA repair systems .

How can insertional mutagenesis be applied to study MutS function in C. caviae?

Insertional mutagenesis provides a powerful approach for studying MutS function in C. caviae. The TargeTron system, which has been successfully applied to C. caviae for other genes such as incA and sinC, represents a suitable method for site-specific disruption of the mutS gene. This technique would allow researchers to directly observe the consequences of MutS deficiency on bacterial phenotype, virulence, and genetic stability .

The methodology would involve:

  • Vector Construction:

    • Design a TargeTron vector specifically retargeted to the mutS gene in C. caviae

    • Replace the β-lactamase (bla) gene in the intron with a chloramphenicol acetyltransferase (cat) gene to enable selection of insertion mutants using chloramphenicol

  • Transformation and Selection:

    • Transform C. caviae with the construct

    • Select for chloramphenicol-resistant colonies

    • Confirm the insertion in the mutS gene through PCR and sequencing

  • Phenotypic Characterization:

    • Analyze spontaneous mutation rates and spectra

    • Assess inclusion morphology and development

    • Examine virulence in appropriate infection models

    • Evaluate DNA damage sensitivity

    • Measure recombination frequencies

This approach would provide direct evidence of MutS function in C. caviae and allow comparison with MutS functions in other bacterial species, potentially revealing unique adaptations in this intracellular pathogen's DNA repair systems .

What are optimal conditions for assessing MutS activity in C. caviae?

Assessing MutS activity in C. caviae requires carefully designed experimental conditions that account for the bacterium's obligate intracellular lifestyle and the complex nature of mismatch repair. The following approaches are recommended:

In Vitro Biochemical Assays:

  • Mismatch Binding Assays:

    • Substrate: Synthetic DNA duplexes (40-60 bp) containing specific mismatches (G:T, A:C, insertion/deletion loops)

    • Buffer conditions: 20-25 mM Tris-HCl (pH 7.5-8.0), 100-150 mM KCl, 5 mM MgCl₂, 1 mM DTT, 5% glycerol

    • Temperature: 30-37°C (physiologically relevant)

    • Detection methods: Electrophoretic mobility shift assay (EMSA) or fluorescence anisotropy with labeled oligonucleotides

  • ATPase Activity Measurement:

    • Substrate: ATP at 1-2 mM concentration

    • Activation: Presence of mismatched DNA to stimulate ATPase activity

    • Detection methods: Malachite green phosphate detection assay or coupled enzyme assay

    • Controls: Include both matched and mismatched DNA substrates to demonstrate specificity

Cell-Based Assays:

  • Mutation Rate Measurement:

    • System: C. caviae strains with wild-type, mutant, or modulated MutS expression

    • Approach: Fluctuation analysis using selective markers

    • Read-out: Frequency of specific types of mutations (transitions vs. transversions)

  • Host Cell-Based Assays:

    • Cell lines: Guinea pig and human epithelial cells

    • Infection conditions: MOI 0.1-1 for single infection events

    • Analysis: Inclusion morphology, developmental cycle progression, and mutation accumulation during infection

These optimized conditions should enable reliable assessment of C. caviae MutS activity while accounting for the unique aspects of this obligate intracellular pathogen.

What methods are most effective for measuring mutation rates resulting from MutS dysfunction in C. caviae?

Measuring mutation rates in C. caviae presents unique challenges due to its obligate intracellular lifestyle and limited genetic tools. Several approaches can be effectively applied to assess how MutS dysfunction affects mutation rates:

1. Fluctuation Analysis with Selective Markers:

  • Implementation: Transform C. caviae with a plasmid containing a gene conferring resistance to an antibiotic (e.g., rifampicin)

  • Procedure: Grow multiple independent cultures and plate on selective media

  • Analysis: Calculate mutation rates using the Luria-Delbrück distribution or the Ma-Sandri-Sarkar maximum likelihood method

  • Advantages: Provides quantitative measurement of mutation rates; well-established methodology

2. Reporter Gene Systems:

  • Design: Introduce a reporter gene (e.g., lacZ) with a premature stop codon or frameshift

  • Measurement: Reversion to functional protein indicates mutation events

  • Detection: Colorimetric assays or fluorescence microscopy of infected cells

  • Advantages: Can detect specific mutation types based on reporter design

3. Deep Sequencing Approaches:

  • Whole Genome Sequencing: Compare mutation accumulation in wild-type vs. MutS-altered strains after defined numbers of passages

  • Analysis: Calculate mutation frequencies, identify hotspots, and characterize mutation spectra

  • Advantages: Provides comprehensive view of mutation patterns; can detect subtle changes

A comprehensive experimental protocol would include:

StageProcedureControls
Strain preparationGenerate wild-type, MutS-deficient, and MutS-overexpressing C. caviaeInclude DNA polymerase proofreading mutants as positive controls
InfectionInfect host cells at low MOI (0.1-0.5)Monitor inclusion formation to confirm infection
GrowthCulture for 48-72 hours to allow completion of developmental cycleInclude uninfected controls
HarvestCollect elementary bodiesConfirm viability and quantity
Mutation detectionPlate on selective media or perform sequencingInclude technical replicates
Rate calculationApply appropriate statistical modelsPerform multiple biological replicates

This multi-faceted approach would provide robust characterization of how MutS dysfunction affects mutation rates and spectra in C. caviae .

How can interspecies recombination experiments inform understanding of MutS function in Chlamydia?

Interspecies recombination experiments offer a powerful approach for dissecting MutS function across Chlamydia species by allowing the creation of chimeric strains and facilitating comparative functional studies. These experiments can be particularly informative given the different host ranges and pathogenicity of various Chlamydia species.

The methodology demonstrated in recent research with Chlamydia species shows that interspecies lateral gene transfer can be achieved through co-infection experiments. Using antibiotic resistance markers positioned at various locations in the chromosome, researchers have generated libraries of recombinant strains carrying chromosomal fragments from different species .

Key experimental approaches for MutS studies could include:

  • Heterologous MutS Expression:

    • Replace the native C. caviae mutS gene with orthologs from other Chlamydia species

    • Compare mismatch repair efficiency, mutation spectra, and phenotypic outcomes

    • Identify species-specific functional adaptations in MutS

  • Domain Swapping:

    • Create chimeric MutS proteins containing domains from different Chlamydia species

    • Identify which domains confer species-specific properties

    • Map functional differences to specific protein regions

  • Implementation Strategy:

    • Generate recombinant strains using established lateral gene transfer methods:

      • Co-infection of host cells with antibiotic-resistant parent strains

      • Selection of recombinants using dual antibiotic pressure

      • Genome sequencing to confirm recombination boundaries

This approach would leverage natural recombination mechanisms in Chlamydia to generate insights into how MutS function has evolved across species and potentially identify adaptations related to host range, tissue tropism, and virulence .

What in vivo models are most appropriate for studying C. caviae MutS function?

Selecting appropriate in vivo models for studying C. caviae MutS function requires consideration of natural host tropism, disease relevance, and experimental feasibility:

1. Chicken Embryo Model:
The chicken embryo infection model has been successfully used to study C. caviae virulence factors. In this model, fertilized chicken eggs are infected at embryonic development day 4, and embryo viability is monitored to assess bacterial virulence. This approach has already revealed the importance of other C. caviae proteins, such as SinC, in virulence. Wild-type C. caviae causes embryo death with a median survival of about 123 hours post-infection .

This model offers several advantages:

  • Demonstrated utility for C. caviae virulence studies

  • Accessible and cost-effective

  • Allows for rapid assessment of pathogen fitness and virulence

  • Can distinguish subtle differences in virulence between strains

2. Guinea Pig Ocular Model:
As C. caviae was originally isolated as an agent of guinea pig inclusion conjunctivitis (GPIC), the guinea pig ocular model represents a natural host-pathogen system. This model would be particularly valuable for studying MutS function in the context of natural infection:

  • Natural host for C. caviae

  • Models the original isolation source

  • Allows assessment of disease progression, inflammatory response, and bacterial adaptation during infection

3. Comparative Host Models:
To study the role of MutS in host adaptation, particularly relevant given the zoonotic potential of some C. caviae strains, parallel infections in guinea pig and human cell culture systems or tissue explants would be valuable:

  • Allows direct comparison of host adaptation processes

  • Enables study of MutS function during host switching

  • Provides insights into mechanisms of zoonotic potential

For all models, comparative studies between wild-type C. caviae and strains with altered MutS function would provide insights into the role of mismatch repair in virulence, persistence, and host adaptation.

How should researchers interpret data on transition mutations resulting from MutS dysfunction?

Interpreting data on transition mutations resulting from MutS dysfunction requires careful consideration of multiple factors:

1. Transition/Transversion Ratio Analysis:
MutS dysfunction typically leads to a characteristic shift in the mutation spectrum, with a significant increase in transition mutations (purine→purine or pyrimidine→pyrimidine) compared to transversion mutations (purine→pyrimidine or vice versa). Research in E. coli demonstrated that MutS overexpression specifically increased GC to AT transition mutations by approximately 3-fold compared to control strains .

2. Contextual Analysis:
When analyzing transition mutations, researchers should:

  • Examine the sequence context surrounding mutation sites for patterns

  • Compare the distribution of mutations across the genome to identify potential hotspots

  • Assess whether certain genes or functional categories are disproportionately affected

3. Correlation with Phenotypic Changes:
Transition mutations should be correlated with:

  • Changes in bacterial fitness

  • Alterations in inclusion morphology or developmental cycle

  • Modifications in host-pathogen interactions

  • Potential effects on antimicrobial susceptibility

4. Statistical Approaches:
Appropriate statistical methods include:

  • Chi-square tests to determine whether the distribution of mutation types differs significantly between wild-type and MutS-altered strains

  • Fisher's exact test for comparing specific mutation types when sample sizes are small

  • Multinomial logistic regression to model the probability of different mutation types as a function of MutS status

5. Data Interpretation Example:
A study in E. coli found that MutS overexpression led to a specific increase in GC to AT transition mutations, which was confirmed through both fluctuation assay and sequencing. The mutation was irreversible as confirmed by colony characteristics and sequencing. The growth-dependent GC to AT transition mutation rate was 3-fold higher in MutS-overexpressing strains than in control strains .

Understanding these transition mutation patterns provides insights into the specific aspects of MutS function that are compromised and the potential evolutionary and pathogenic consequences for C. caviae.

How might MutS function relate to C. caviae's interspecies recombination capabilities?

MutS function likely plays a significant role in regulating C. caviae's interspecies recombination capabilities through several mechanisms:

  • Mismatch Recognition During Recombination: MutS recognizes mismatches in heteroduplex DNA formed during recombination between sequences from different species. The efficiency of this recognition may influence which recombination events are successful, potentially affecting the bacterium's ability to acquire new genetic material through horizontal gene transfer.

  • Regulation of Recombination Frequency: In some bacterial systems, MutS homologs can prevent recombination between divergent sequences, a phenomenon known as homeologous recombination inhibition. The strength of this inhibition in C. caviae could influence its capacity for interspecies genetic exchange.

  • Impact on Recombination Boundaries: Research on chromosomal recombination in Chlamydia has identified candidate recombination hot spots. MutS may influence the location and extent of these recombination events, potentially shaping the size and composition of transferred genomic fragments .

  • Role in Post-Recombination Stability: Following interspecies recombination, MutS likely plays a critical role in maintaining the stability of the acquired sequences, particularly if they contain mismatches or are otherwise recognized as foreign by the cell's repair systems.

Recent work has demonstrated that interspecies genetic exchange can occur between Chlamydia species, with fragments encompassing 79% of one species' chromosome being successfully introduced into another species' background. Understanding MutS's role in this process could provide insights into the mechanisms controlling horizontal gene transfer in these important pathogens and potentially explain the limited evidence of recent foreign DNA acquisition in natural Chlamydia populations .

What are the implications of MutS research for understanding C. caviae pathogenesis?

MutS research has significant implications for understanding C. caviae pathogenesis through several key aspects:

  • Virulence Factor Stability: MutS ensures the genetic stability of virulence factors, which is crucial for maintaining pathogenic potential. Research with other C. caviae virulence factors, such as IncA and SinC, has demonstrated their importance in inclusion development and virulence in vivo. MutS-mediated DNA repair likely plays a critical role in preserving the function of these and other virulence determinants .

  • Adaptation During Infection: During infection, C. caviae must adapt to various microenvironments within the host. MutS may help balance genomic stability with adaptive potential, allowing the pathogen to respond to host defenses while maintaining core functions.

  • Host Range Determination: C. caviae strains show varying zoonotic potential, with some causing severe respiratory infections in humans despite primarily being guinea pig pathogens. MutS function may influence host range by affecting the bacterium's ability to acquire adaptive mutations or through its role in maintaining genomic integrity during host switching .

  • Developmental Cycle Regulation: C. caviae has a complex biphasic developmental cycle, transitioning between elementary bodies (EBs) and reticulate bodies (RBs). MutS function may be differentially regulated during this cycle, potentially affecting the fidelity of DNA replication during the metabolically active RB stage.

  • Inclusion Morphology Influence: Research has shown that other C. caviae proteins, such as IncA, significantly affect inclusion morphology, with IncA-deficient mutants forming multiple non-fusogenic inclusions. MutS may indirectly influence inclusion development by ensuring the genetic stability of proteins involved in this process .

Understanding these aspects of MutS function in C. caviae pathogenesis could provide new insights into chlamydial virulence mechanisms and potentially identify novel targets for therapeutic intervention.

How can statistical methods best analyze the mutation spectra resulting from MutS dysfunction?

Analyzing mutation spectra resulting from MutS dysfunction requires sophisticated statistical approaches that can detect significant patterns while accounting for the complex nature of mutational processes:

1. Descriptive Statistical Methods:

  • Transition/Transversion Ratios: Calculate and compare the ratio of transition mutations to transversion mutations. MutS dysfunction typically increases transition mutations, particularly G:C→A:T, as demonstrated in E. coli research where MutS overexpression resulted in a 3-fold increase in GC to AT transition mutations .

  • Mutation Type Distribution: Categorize mutations into six possible base substitution types (C→T, C→A, C→G, T→C, T→A, T→G) and their reverse complements, and compare distributions between wild-type and MutS-altered strains.

2. Comparative Statistical Methods:

  • Chi-Square Tests: Apply to determine whether the distribution of mutation types differs significantly between wild-type and MutS-altered strains.

  • Fisher's Exact Test: Particularly useful for comparing specific mutation types when sample sizes are small, as might be the case in initial studies of C. caviae mutants.

  • Multinomial Logistic Regression: Model the probability of different mutation types as a function of MutS status and other variables such as genomic position or sequence context.

3. Advanced Statistical Approaches:

  • Bayesian Framework: Implement Bayesian models to estimate mutation parameters while incorporating prior knowledge about MutS function.

  • Non-negative Matrix Factorization (NMF): Apply to decompose the mutation spectrum into distinct signatures that may represent different mutational processes.

  • Principal Component Analysis (PCA): Use to visualize and compare mutation patterns between different experimental conditions.

4. Implementation Example:
A comprehensive statistical analysis pipeline for C. caviae MutS mutation spectra could include:

  • Generation of mutation catalogs from whole genome sequencing of wild-type, MutS-deficient, and MutS-overexpressing strains

  • Initial characterization using transition/transversion ratios and mutation type distributions

  • Application of chi-square tests to identify significant differences in mutation patterns

  • Multinomial regression analysis incorporating genomic features such as GC content and gene density

  • Comparison with mutation patterns observed in other Chlamydia species or clinical isolates

These statistical approaches would provide robust insights into how MutS dysfunction affects the mutation landscape in C. caviae, potentially revealing unique aspects of mismatch repair function in this organism .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.